Tag: Artemis Medicare

  • Artemis Medicare Stock Hits Record High, Surges 14% on Heavy Trading Volume

    Artemis Medicare Stock Hits Record High, Surges 14% on Heavy Trading Volume

    Shares of Artemis Medicare Services reached a new all-time high on Friday, September 25, climbing as much as 14% to Rs. 378.40 on the BSE. The rally pushed the stock past its previous peak of Rs. 361.50, set on September 10, and extended a strong year for the hospital operator.

    The stock has gained nearly 40% in 2026, while the broader Sensex index has dropped around 12% over the same period. From its 52-week low of Rs. 202.85 touched in April, Artemis Medicare has now recovered approximately 87%.

    Heavy Trading Drives the Rally

    Trading volumes were notably high on Friday. Around 11:38 AM, the stock was trading 10% higher at Rs. 365.55 even as the broader market remained flat. Approximately 12.75 million shares changed hands across the NSE and BSE, representing nearly 8% of the company’s total equity.

    Artemis Medicare operates more than 800 hospital beds, primarily in the Delhi-NCR region. Its flagship hospital in Gurugram has over 700 beds and holds both JCI and NABH accreditation. The company also runs a cardiac-care joint venture with Philips and has a presence in Mauritius.

    The Gurugram facility continues to benefit from improved bed utilization, higher earnings per bed, and steady demand for specialized treatments. A new hospital in Raipur, which opened in July, adds another growth market. International patients from the Middle East, Africa, and the CIS region continue to contribute to demand.

    Brokerage Sees More Room to Grow

    InCred Equities has initiated coverage on the stock with a target price of Rs. 437. The brokerage expects revenue, EBITDA, and profit to grow between 23% and 28% annually through FY28, supported by new beds from the Raipur hospital and the upcoming Gurgaon Tower IV project.

    Artemis has also approved a plan to raise up to Rs. 700 crore through a qualified institutional placement (QIP) for future acquisitions, though no specific deal has been announced yet. With new capacity coming online and funds available for acquisitions, Artemis Medicare appears well-positioned to remain in the spotlight in the coming months.